Full name
MS-PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
49.41.Z - Road freight transport
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,8 | 0,4 | 0,1 | -64,7 |
EBITDA | 1,1 | 0,7 | 0,3 | -47,2 |
Short time liabilities | 5,3 | 4,8 | 5 | 4,2 |
Equity capital | 2 | 2,3 | 2,5 | 6,6 |
Operating profit (EBIT) | 0,8 | 0,4 | 0,2 | -61,5 |
Assets | 7,5 | 7,3 | 7,6 | 4,8 |
Net profit (loss) | 0,8 | 0,3 | 0,2 | -54 |
Cash | 2,2 | 2,3 | 2,3 | 2,7 |
Net income from sale | 28,8 | 30,5 | 30,3 | -0,6 |
Liabilities and provisions for liabilities | 5,5 | 4,9 | 5,1 | 3,9 |
Working assets | 6,6 | 6,5 | 7 | 7,2 |
Depreciation | 0,3 | 0,2 | 0,2 | -20,1 |
% | % | % | p.p. | |
Profitability of capital | 38,6 | 14,4 | 6,2 | -8,2 |
Equity capital to total assets | 26,7 | 32,2 | 32,8 | 0,6 |
Gross profit margin | 2,8 | 1,3 | 0,5 | -0,8 |
EBITDA Margin | 3,8 | 2,2 | 1,2 | -1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 67 | 58 | 61 | 3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane